These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 6354607)

  • 1. Double-blind evaluation of low-dose proglumetacin versus naproxen in rheumatoid arthritis out-patients.
    Espŕito Santo J; da Silva JP; da Costa JT; Gomes JM; Queiroz MV
    Curr Med Res Opin; 1983; 8(7):524-30. PubMed ID: 6354607
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A 3-month, double-blind study of proglumetacin and naproxen in the treatment of rheumatoid arthritis.
    Bozsoky S; Zahumenszky Z
    Curr Med Res Opin; 1982; 8(2):89-96. PubMed ID: 7049588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical study of patients with primary polyarthritis. Cross-over comparative study of proglumetacin and naproxen].
    Pellegrini P; Cervi G; Corcione S
    Minerva Med; 1983 Jun; 74(26):1525-8. PubMed ID: 6343924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Double-blind comparison of etodolac and naproxen in the treatment of rheumatoid arthritis.
    de Queiros MF
    Clin Ther; 1991; 13(1):38-46. PubMed ID: 1827613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Maintenance therapy of rheumatoid arthritis and of osteoarthrosis with proglumetacin.
    Bozsóky S; Zahumenszky Z
    Pharmatherapeutica; 1983; 3(5):305-13. PubMed ID: 6844368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Etodolac versus naproxen in rheumatoid arthritis: a double-blind crossover study.
    Waltham-Weeks CD
    Curr Med Res Opin; 1987; 10(8):540-7. PubMed ID: 2960494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proglumetacin (protacine): a promising new treatment of the rheumatic joint.
    Rivera IC
    Pharmatherapeutica; 1982; 3(3):169-73. PubMed ID: 6982477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A double-blind, comparative study of diflunisal and naproxen in the treatment of rheumatoid arthritis.
    Devereaux MD; Douglas WA
    Eur J Rheumatol Inflamm; 1983; 6(3):274-8. PubMed ID: 6391932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical evaluation of proglumetacin malate in rheumatoid arthritis--a multi-institutional cooperative study].
    Ryumachi; 1986 Oct; 26(5):377-88. PubMed ID: 3299753
    [No Abstract]   [Full Text] [Related]  

  • 10. [Treatment of chronic polyarthritis. Double-blind study with proglumetacin compared to diclofenac].
    Grosse-Kielisch C; Bach GL
    MMW Munch Med Wochenschr; 1983 Nov; 125(47):1105-6. PubMed ID: 6419067
    [No Abstract]   [Full Text] [Related]  

  • 11. International experience with etodolac therapy for rheumatoid arthritis: an interim report of comparative efficacy.
    Briancon D
    Clin Rheumatol; 1989 Mar; 8 Suppl 1():63-72. PubMed ID: 2525985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Conservative therapy of activated gonarthrosis. Double-blind study of proglumetacine and piroxicam].
    Puhl W; Springorum HW
    Fortschr Med; 1984 Jun; 102(23):653-6. PubMed ID: 6381269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Controlled evaluation of nabumetone in the treatment of active adult rheumatoid arthritis. Nabumetone versus naproxen double-blind parallel study.
    Vasey FB; Germain BF; Espinoza LR; Box P; Bockow BI; Lipani JA; Mullen BJ; Brodsky AL; Fleischmann RM; Fogari RA
    Am J Med; 1987 Oct; 83(4B):55-9. PubMed ID: 3318430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Piroxicam versus naproxen in rheumatoid arthritis.
    Mbuyi-Muamba JM; Dequeker J
    Curr Med Res Opin; 1983; 8(9):612-7. PubMed ID: 6607819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparative study of the effectiveness and safety of two non-steroidal anti-inflammatory agents, nabumetone and naproxen in rheumatoid arthritis.
    Fostiropoulos G; Croydon EA
    J Int Med Res; 1982; 10(4):204-8. PubMed ID: 6749576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A double-blind gastroscopic evaluation of the effects of etodolac and naproxen on the gastrointestinal mucosa of rheumatic patients.
    Bianchi Porro G; Caruso I; Petrillo M; Montrone F; Ardizzone S
    J Intern Med; 1991 Jan; 229(1):5-8. PubMed ID: 1825323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single-blind comparative study of nabumetone (Relafen) versus naproxen in the treatment of rheumatoid arthritis.
    Hazleman BL; Thomas PP
    Am J Med; 1987 Oct; 83(4B):60-4. PubMed ID: 3318431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Double-blind multicentre UK hospital studies of isoxicam vs naproxen.
    Cardoe N; Hart FD
    Br J Clin Pharmacol; 1986; 22 Suppl 2(Suppl 2):167S-172S. PubMed ID: 3620277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A six-month parallel group comparison of fenbufen and naproxen in the treatment of rheumatoid arthritis.
    Khan FM
    Clin Ther; 1983; 5(5):483-7. PubMed ID: 6352034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect on gastric and duodenal mucosal prostaglandins of repeated intake of therapeutic doses of naproxen and etodolac in rheumatoid arthritis.
    Taha AS; McLaughlin S; Holland PJ; Kelly RW; Sturrock RD; Russell RI
    Ann Rheum Dis; 1990 Jun; 49(6):354-8. PubMed ID: 2143369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.